| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2024 | 3 | 43,659 | KYTX, VIGL, CADL | 13F-HR | 11/14/2024 | 000110465924118975 |
| Q2 2024 | 4 | 55,268 | KYTX, VIGL, CADL, TELESIS BIO INC | 13F-HR | 8/14/2024 | 000110465924089657 |
| Q1 2024 | 4 | 102,625 | KYVERNA THERAPEUTICS INC, VIGL, TBIO, CADL | 13F-HR | 5/15/2024 | 000110465924061943 |
| Q4 2023 | 3 | 21,017 | VIGL, TBIO, CADL | 13F-HR | 2/14/2024 | 000110465924023717 |
| Q3 2023 | 3 | 34,734 | VIGL, TBIO, CADL | 13F-HR | 11/14/2023 | 000110465923118119 |
| Q2 2023 | 4 | 60,249 | VIGL, TBIO, BLI, CADL | 13F-HR | 8/14/2023 | 000110465923091394 |
| Q1 2023 | 5 | 174,983 | DICE, VIGL, TBIO, BLI | 13F-HR | 5/15/2023 | 000110465923060801 |
| Q4 2022 | 5 | 184,349 | DICE, VIGL, ISO, TBIO | 13F-HR | 2/1/2023 | 000110465923009328 |
| Q3 2022 | 5 | 142,700 | DICE, VIGL, TBIO, ISO | 13F-HR | 11/14/2022 | 000110465922117428 |
| Q2 2022 | 5 | 104,993 | DICE, ISO, TBIO, VIGL | 13F-HR | 8/1/2022 | 000110465922084803 |
| Q1 2022 | 5 | 185,547 | DICE, TBIO, ISO, VIGL | 13F-HR | 5/16/2022 | 000110465922060755 |
| Q4 2021 | 4 | 285,713 | TBIO, DICE, ISO, CADL | 13F-HR | 2/15/2022 | 000110465922023765 |